ZYBT
NASDAQ · Pharmaceuticals
Zhengye Biotechnology Holdin
$1.82
-0.27 (-12.92%)
Open$2.39
Previous Close$2.09
Day High$3.59
Day Low$1.66
52W High$13.08
52W Low$0.62
Volume—
Avg Volume7.89M
Market Cap38.05M
P/E Ratio—
EPS$-1.93
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 51.38M | 12.11M | 10.68M |
| Net Income | -30,810,517 | 2.69M | 1.92M |
| Profit Margin | -60.0% | 22.3% | 18.0% |
| EBITDA | -19,701,338 | 3.66M | 3.67M |
| Free Cash Flow | — | 1.61M | 1.47M |
| Rev Growth | +664.7% | -0.1% | -5.4% |
| Debt/Equity | 0.30 | 0.37 | 0.43 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |